165 related articles for article (PubMed ID: 1082642)
1. [Antibodies against various nuclear antigens (especially DNA and RNA proteins) in disseminated lupus erythematosus with and without kidney involvement and in other collagen diseases. Preliminary report].
Mulli JC; Cruchaud A
Schweiz Med Wochenschr; 1975 Dec; 105(50):1724-5. PubMed ID: 1082642
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity to nuclear antigens in systemic lupus erythematosus with or without nephritis, and in other connective tissue diseases, with particular reference to the RNA-protein antigen.
Mulli JC; Cruchaud A
Int Arch Allergy Appl Immunol; 1977; 53(3):279-89. PubMed ID: 300712
[TBL] [Abstract][Full Text] [Related]
3. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients.
Farber SJ; Bole GG
Arch Intern Med; 1976 Apr; 136(4):425-31. PubMed ID: 1083722
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases.
Maddison P; Mogavero H; Provost TT; Reichlin M
J Rheumatol; 1979; 6(2):189-95. PubMed ID: 88520
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
[TBL] [Abstract][Full Text] [Related]
7. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
[TBL] [Abstract][Full Text] [Related]
8. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
[TBL] [Abstract][Full Text] [Related]
9. Arthritis and nephritis in patients with systemic lupus erythematosus.
Kaplan D; Ginzler EM; Feldman J
J Rheumatol; 1991 Feb; 18(2):223-9. PubMed ID: 2023215
[TBL] [Abstract][Full Text] [Related]
10. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
11. [Nephritis and the presence of antiribonucleoprotein antibodies in disseminated lupus erythematosus in children and adolescents].
Lapointe ND; Carrenö-Perrez L; Pelletier M; Déom P; Robitaille P
Union Med Can; 1985 Jun; 114(6):490-2. PubMed ID: 3875176
[No Abstract] [Full Text] [Related]
12. Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis.
Andres GA; Accinni L; Beiser SM; Christian CL; Cinotti GA; Erlanger BF; Hsu KC; Seegal BC
J Clin Invest; 1970 Nov; 49(11):2106-18. PubMed ID: 4097660
[TBL] [Abstract][Full Text] [Related]
13. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a distinct nuclear acidic protein antigen (MA) and clinical findings in systemic lupus erythematosus patients with MA antibodies.
Winn DM; Wolfe JF; Harmon D; Sharp GC
J Clin Invest; 1979 Sep; 64(3):820-3. PubMed ID: 89119
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
Parker MD; Turner RA
Arthritis Rheum; 1976; 19(5):857-61. PubMed ID: 786297
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
17. Anti-dsDNA antibodies in sera of patients without systemic lupus erythematosus.
Wollina U
Allerg Immunol (Leipz); 1984; 30(4):222-4. PubMed ID: 6240935
[TBL] [Abstract][Full Text] [Related]
18. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
[TBL] [Abstract][Full Text] [Related]
19. [Anti-DNA determination using Crithidia luciliae. Specificity and clinical usefulness in systemic lupus erythematosus].
Pena Sagredo JL; Orte Martinez FJ; Sanchez Andrada S; Sampedro Alvarez J; Novo Fernandez MJ; Rodriguez Valverde V
Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):345-50. PubMed ID: 7048503
[TBL] [Abstract][Full Text] [Related]
20. [Specificity of antinuclear autoantibodies in diseases with systemic destruction of connective tissue].
Shekhonin BV; Trusov OA; Butov IuS
Biull Eksp Biol Med; 1977 Jul; 84(7):75-8. PubMed ID: 329917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
